High-dose sugammadex speeds reversal of neuromuscular block

High-dose sugammadex speeds reversal of neuromuscular block

(HealthDay)—Sugammadex at a dose of 4 mg/kg−1 of ideal body weight allows for shorter reversal of deep neuromuscular blockade in morbidly obese patients, according to a study published in the March issue of Anaesthesia.

Thibault Loupec, M.D., from the University of Poitiers in France, and colleagues conducted a single-center randomized trial in 50 morbidly . Neuromuscular blockade was monitored using acceleromyography at the adductor pollicis. Patients were randomized to sugammadex 4 mg/kg−1 (high-dose group), 2 mg/kg−1 (middle-dose group), and 1 mg/kg−1 (low-dose group) of ideal at the end of surgery with deep rocuronium-induced neuromuscular blockade.

The researchers found that the mean recovery time from deep neuromuscular blockade was significantly shorter in the high-dose group versus the middle- or low-dose group after administration of the first dose of sugammadex (255 versus 429 and 581 seconds, respectively; P < 0.001). For the high-, middle-, and low-dose groups, success rates were 93, 77, and 22 percent, respectively, from neuromuscular blockade reversal defined by a train-of-four ≥0.9 within 10 minutes after sugammadex administration (P < 0.05 compared with the lose-dose group).

"In patients, 4 mg/kg−1 of weight of sugammadex allows suitable reversal of deep rocuronium-induced neuromuscular blockade," the authors write. "Monitoring remains essential to detect residual curarisation or recurarisation."

One author disclosed financial ties to Merck Sharp & Dohme.

Explore further

Higher costs for traditional-dose isotretinoin therapy

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Anaesthesia

Copyright © 2016 HealthDay. All rights reserved.

Citation: High-dose sugammadex speeds reversal of neuromuscular block (2016, February 19) retrieved 2 October 2022 from https://medicalxpress.com/news/2016-02-high-dose-sugammadex-reversal-neuromuscular-block.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors